Currently, VEGF-C is the exclusive factor used to stimulate MLVs in preclinical models of brain diseases, but the mechanisms mediating VEGF-C action in the meninges as well as in the brain remain poorly understood. The gene discussed is VEGFC; the disease is brain disorder.